The cytokine CSF-1 (M-CSF) expressed by endometrial carcinomas in vivo and in vitro, may also be a circulating tumor marker of neoplastic disease activity in endometrial carcinoma patients.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  1990-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0360-3016(90)90488-6PMID 2145248
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Ovarian adenocarcinomas express fms-complementary transcripts and fms antigen, often with coexpression of CSF-1.

  1990cited by this paper
• Various Human Hematopoietic Growth Factors (Interleukin-3, GM-CSF, G-CSF) Stimulate Clonal Growth of Nonhematopoietic Tumor Cells

  1989cited by this paper
• Oncogene expression in vivo by ovarian adenocarcinomas and mixed-mullerian tumors.

  1989cited by this paper
• Increased circulating CSF-1 (M-CSF) in myeloproliferative disease: association with myeloid metaplasia and peripheral bone marrow extension.

  1989cited by this paper
• Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells.

  1989cited by this paper
• Circulating levels of CSF-1 (M-CSF) a lymphohematopoietic cytokine may be a useful marker of disease status in patients with malignant ovarian neoplasms.

  1989cited by this paper
• Monoclonal antibodies to phosphotyrosine.

  1988cited by this paper
• Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin.

  1988cited by this paper
• High level expression of fms proto-oncogene mRNA is observed in clinically aggressive human endometrial adenocarcinomas.

  1988cited by this paper
• The human hematopoietic colony-stimulating factors.

  1987cited by this paper
• Colony‐stimulating factor‐1 induces thromboplastin activity in murine macrophages and human monocytes

  1987cited by this paper
• Apparent role of the macrophage growth factor, CSF-1, in placental development

  1987cited by this paper
• Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus

  1986cited by this paper
• Expression of the human c-fms proto-oncogene product (colony-stimulating factor-1 receptor) on peripheral blood mononuclear cells and choriocarcinoma cell lines.

  1986cited by this paper
• Characterization of the human c-fms gene product and its expression in cells of the monocyte-macrophage lineage

  1985cited by this paper
• Human colony-stimulating factor (CSF-1) radioimmunoassay: resolution of three subclasses of human colony-stimulating factors.

  1981cited by this paper
• Number and evolutionary conservation of α- and β-tubulin and cytoplasmic β- and γ-actin genes using specific cloned cDNA probes

  1980cited by this paper
• Number and evolutionary conservation of alpha- and beta-tubulin and cytoplasmic beta- and gamma-actin genes using specific cloned cDNA probes.

  1980cited by this paper
• The establishment of a cell line of human hormone-synthesizing trophoblastic cells in vitro.

  1968cited by this paper

• Haloperidol Instigates Endometrial Carcinogenesis and Cancer Progression by the NF-κB/CSF-1 Signaling Cascade

  2022cites this paper
• Increased Soluble CrkL in Serum of Breast Cancer Patients Is Associated with Advanced Disease

  2019cites this paper
• Endometrial Carcinoma: Specific Targeted Pathways.

  2017cites this paper
• miR-1207-5p suppresses lung cancer growth and metastasis by targeting CSF1

  2016cites this paper
• Luteinizing hormone is a primary culprit in the endometrial carcinoma development in elderly women

  2016cites this paper
• Modulating the tumor microenvironment with RNA interference as a cancer treatment strategy.

  2015cites this paper
• Colony-Stimulating Factor-1 Receptor in the Polarization of Macrophages:A Target for Turning Bad to Good Ones?

  2015cites this paper
• TARGETING BREAST CANCER WITH BACTERIOPHAGE ASSOCIATED SILICON PARTICLES

  2014cites this paper
• Hematopoietic cytokines as tumor markers in breast malignancies. A multivariate analysis with ROC curve in breast cancer patients.

  2013cites this paper
• The prognostic significance of the innate and adaptive immune systems in non-small cell lung carcinoma

  2010cites this paper
• Study of drug delivery and cell encapsulation using biocompatible hydrogel

  2010cites this paper
• Targeting stromal-cancer cell interactions with siRNAs.

  2009cites this paper
• Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor.

  2009cites this paper
• A novel function of colony-stimulating factor 1 receptor in hTERT immortalization of human epithelial cells

  2009cites this paper
• Role of CSF-1 in progression of epithelial ovarian cancer.

  2009cites this paper
• Endometrial cancer: multiplexed Luminex approaches for early detection.

  2008cites this paper
• Comparative evaluation of plasma levels and diagnostic values of macrophage-colony stimulating factor in patients with breast cancer and benign tumors.

  2008cites this paper
• Target validation using RNA interference in solid tumors.

  2007cites this paper
• Markery nowotworowe przydatne w diagnostyce i monitorowaniu raka endometrium i szyjki macicy Tumor markers useful in the diagnostics and monitoring of endometrial and cervical cancer

  2007cites this paper
• A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model

  2006cites this paper
• The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.

  2006cites this paper
• Cancer cell‐secreted proteomes as a basis for searching potential tumor markers: Nasopharyngeal carcinoma as a model

  2005cites this paper
• The Role of CSF-1 in Normal Physiology of Mammary Gland and Breast Cancer: An Update

  2004cites this paper
• cDNA microarray analysis of invasive and tumorigenic phenotypes in a breast cancer model

  2004cites this paper
• Macrophage Colony-Stimulating Factor-1 Receptor Expression Is Associated with Poor Outcome in Breast Cancer by Large Cohort Tissue Microarray Analysis

  2004cites this paper
• Hematopoietic cytokines as tumor markers.

  2004cites this paper
• Expression of CSF-1 and its receptor CSF-1R in non-hematopoietic neoplasms.

  2002cites this paper
• Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice.

  2002cites this paper
• Circulating macrophage colony stimulating factor as a marker of tumour progression.

  2002cites this paper
• Granulocyte-Colony Stimulating Factor (G-CSF) and Macrophage-Colony Stimulating Factor (M-CSF) in Colorectal Cancer Patients

  2002cites this paper
• Colony-stimulating Factor-1 Antisense Treatment Suppresses Growth of Human Tumor Xenografts in Mice 1

  2002cites this paper
• ENDOMETRİUM KANSERİNDE PROGNOSTİK FAKTÖRLER

  2001cites this paper
• Granulocyte-Colony Stimulating Factor and Macrophage-Colony Stimulating Factor in Patients with Non-Small-Cell Lung Cancer

  2001cites this paper
• Hematopoietic cytokines as tumor markers

  2001cites this paper
• Serum levels of macrophage colony-stimulating factor in trophoblastic disease.

  2001cites this paper
• The constitutive production of colony stimulating factor 1 by invasive human breast cancer cells.

  2000cites this paper
• Signal transduction pathways regulated by CSF-1 receptors modulate the in vitro radiosensitivity of mammary epithelial cells.

  1999cites this paper
• Macrophage colony-stimulating factor (M-CSF) production in vivo and in vitro in gynecologic malignancies

  1999cites this paper
• The Role of CSF-1 in Normal and Neoplastic Breast Physiology

  1999cites this paper
• The role of CSF-1 in normal and neoplastic breast physiology.

  1999cites this paper
• Colony-stimulating factor-1 and its receptor do not have a role in the pathogenesis of uterine sarcomas.

  1999cites this paper
• Synthesis and breakdown of fibrillar collagens: concomitant phenomena in ovarian cancer.

  1998cites this paper
• Prognostic factors in ovarian cancer.

  1998cites this paper
• CSF‐1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract

  1997cites this paper
• Macrophage colony-stimulating factor as a marker of ovarian carcinoma.

  1997cites this paper
• The molecular genetics of endometrial carcinoma.

  1997cites this paper
• Preoperative evaluation of macrophage colony-stimulating factor levels in patients with endometrial cancer.

  1996cites this paper
• Independent regulation of invasion and anchorage-independent growth by different autophosphorylation sites of the macrophage colony-stimulating factor 1 receptor.

  1996cites this paper
• Biological activity of the receptor for macrophage colony-stimulating factor in the human endometrial cancer cell line, Ishikawa.

  1996cites this paper
• Serum level of macrophage colony-stimulating factor as a marker for gynecologic malignancies.

  1995cites this paper
• Regulation of the c-fms promoter in murine tumour cell lines.

  1995cites this paper
• Molecular basis of endometrial cancer

  1995cites this paper
• CSF-1 and its receptor in ovarian, endometrial and breast cancer.

  1995cites this paper
• Cytokines as tumour markers.

  1995cites this paper
• Biomarkers in the endometrium

  1995cites this paper
• The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma.

  1995cites this paper
• Macrophage colony-stimulating factor 1, a clinically useful tumor marker in endometrial adenocarcinoma: comparison with CA 125 and the aminoterminal propeptide of type III procollagen.

  1995cites this paper
• Increased expression of luteinizing hormone/human chorionic gonadotropin receptor gene in human endometrial carcinomas.

  1994cites this paper
• Co‐expression of M‐CSF transcripts and protein, FMS (M‐CSF receptor) transcripts and protein, and steroid receptor content in adenocarcinomas of the ovary

  1994cites this paper
• Elevated endogenous serum macrophage colony-stimulating factor in the early stage of fungemia following bone marrow transplantation.

  1994cites this paper
• Co-cultivation of ovarian carcinoma cells with dermal fibroblasts induces fibroblast expression of sex steroid receptor transcripts and protein

  1994cites this paper
• Colony-stimulating factor-1 in primary ascites of ovarian cancer is a significant predictor of survival.

  1993cites this paper
• Macrophage Colony-Stimulating Factor as a Tumor Marker for Epithelial Ovarian Cancer

  1993cites this paper
• Increased serum levels of macrophage colony‐stimulating factor in ovarian cancer

  1992cites this paper
• Colony-stimulating factors in the clinic.

  1992cites this paper
• Mutations of the Ki-ras oncogene in endometrial carcinoma.

  1992cites this paper
• NEU protein overexpression in benign, borderline, and malignant ovarian neoplasms.

  1992cites this paper
• The Use of Tumor Markers in the Management of Patients with Gynecologic Carcinomas

  1992cites this paper
• Analysis of oncogene alterations in human endometrial carcinoma: Prevalence of ras mutations

  1991cites this paper
• FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinomas in vivo and in vitro.

  1991cites this paper
• Oncogenes in Endometrial Cancer: A Review of Information

  1991cites this paper
• Increased serum levels of macrophage colony-stimulating factor in ovarian cancer.

  1991cites this paper
• Endometrial cancer: biochemical and clinical correlates.

  1991cites this paper